Victoza, Saxenda, Ozempic, Wegovy, Rybelsus its not hard to see that Novo Nordisk has become a giant in this space, pioneering first- and second-in-class GLP-1RA obesity medications
Moreover, fasting hyperglycaemia was responsible for 2.3 million cardiovascular deaths worldwide in 2021 [2]
What we can tell you is that our clinic does not place every patient on permanent medication
And this is something scientists are considering as they continue to monitor and study GLP-1s and their effects
What helps: A personalized training approach can help you navigate exercise safely during this adjustment period
This program covers the cost of corrective treatments, such as liposuction, for those diagnosed with PAH after CoolSculpting